Max Healthcare Institute Ltd.

NSE: MAXHEALTH · Healthcare

₹1,000.10

as of 28 Sep 2026

AI verdict · 28 Sep 2026

Bearish 62% confidence

Bearish EMA stack, RSI in bearish regime, and Q1 QoQ margin declines outweigh YoY growth; Q2 results are critical to validate deterioration.

Strongest bull point

Q1 FY27 showed strong YoY revenue (+16.70%) and operating profit (+14.45%) growth with dividend continuity, and RSI at 44 leaves room for stabilization before oversold extremes.

Strongest bear point

Price is below all three EMAs in bearish stack, RSI is firmly bearish at 44.14, and Q1 results show concerning QoQ declines in operating profit (-1.32%) and PBDT (-3.34%) despite YoY growth.

Technical Forecast · next 10 trading days

Expected

₹1,008.89 +0.9%

Range

₹1,006.04 – ₹1,012.55

Technical Forecast Fundamental Debate

Free: 5 Forecasts and 5 Debates a month. Log in with your mobile number.

Every call on MAXHEALTH, misses included

Bearish 28 Sep 2026 → now Scores 28 Oct 2026

₹1,000.10 → ₹1,000.10 0.0%

Our accuracy

Every verdict and forecast here is dated and scored when it matures — right or wrong. The first scored results publish a month after launch.

How we score →

More Healthcare